Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Ventyx Biosciences, Inc. (VTYX) Investors
Investors have until April 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- Investors have until April 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- On November 6, 2023, Ventyx issued a press release announcing results from its Phase 2 SERENITY Trial.
- Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
- The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.